* Zepp Health Corp ZEPP.N ZEPP.K is expected to show a rise
in quarterly revenue when it reports results on August 19.
* The Hefei, Anhui-based company is expected to report a
58.5% increase in revenue to CNY1.803 billion from CNY1.14
billion a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Zepp Health Corp is for
earnings of CNY1.50 per share. For the same quarter last year,
the company reported earnings of 30 fen per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Zepp Health
Corp is $13.3, about 25.9% above its last closing price
of $9.86.
* Previous quarterly performance (using preferred earnings
measure in Chinese yuan renminbi).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 0.49 0.49 -0.46 Missed -194.1
Dec. 31 2020 1.43 1.43 1.96 Beat 37.4
Sep. 30 2020 2.56 2.62 1.85 Missed -29.4
Jun. 30 2020 0.35 0.35 0.30 Missed -14.9
Mar. 1.00 1.17 0.39 Missed -66.6
31 2020
Dec. 31 2019 3.42 3.04 3.31 Beat 8.9
Sep. 30 2019 2.70 2.70 3.25 Missed 20.4
Jun. 30 2019 1.72 1.72 0.25 Beat 0.6
This summary was machine generated August 17 at 11:09 GMT. All
figures in Chinese yuan renminbi unless otherwise stated